(Q53043857)

10 May 2018

title

MELPHALAN THERAPY IN MYELOMATOSIS. (English)

1 reference

10 May 2018

author name string

WALDENSTROEM J

series ordinal

1

1 reference

10 May 2018

language of work or name

English

0 references

publication date

1 April 1964

1 reference

10 May 2018

number of pages

7

1 reference

inferred from page(s)

published in

The BMJ

1 reference

10 May 2018

volume

1

1 reference

10 May 2018

issue

5387

1 reference

10 May 2018

page(s)

859-865

1 reference

10 May 2018

Multiple myeloma. III. Effect of urethane therapy on plasma cell growth, abnormal serum protein components and Bence Jones proteinuria

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1814043

Multiple plasmocytoma treated with urethane.

22 May 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1814043

Treatment of multiple myeloma with urethan; experience with 66 cases over a 2 1/2 year period.

13 August 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1814043

[Clinical experiences with sarcolysin in neoplastic diseases]

13 August 2018

1 reference

12 December 2020

Phase II trials of mitomycin C, AB-100, NSC-1026, L-sarcolysin, and meta-sarcolysin, in the treatment of multiple myeloma

1 reference

12 December 2020

Case of multiple myeloma complicated by agranulocytosis

1 reference

12 December 2020

Attempt at treatment of 21 patients with myeloma or macroglobulinemia with p-di-2-chlorethylamino-1-phenylalanine (melphalan)

1 reference

12 December 2020

Identifiers

DOI

10.1136/BMJ.1.5387.859

1 reference

10 May 2018

PMCID

1814043

1 reference

10 May 2018

PubMed ID

14102769

1 reference

10 May 2018